UNIVERSITY OF KENTUCKY
Gold-derived therapeutic compounds for disease application
Gold-derived therapeutic compounds for disease application is a funding opportunity from UNIVERSITY OF KENTUCKY, up to 336989, closing July 31, 2027.
Jul 31, 2027
(365d left)Overview
PROJECT SUMMARY/ABSTRACT. Gold-derived anticancer compounds are promising therapeutic agents for disease applications, including cancer. Triple negative breast cancer (TNBC) is an aggressive clinical subtype of breast cancer that lacks effective therapy. Approximately, 66% of all breast cancer deaths are TNBC-related,…